白三烯及抗白三烯药物与皮肤病相关性的研究进展
![白三烯及抗白三烯药物与皮肤病相关性的研究进展](https://img.360docs.net/imgcf/068bexqzrgf1vyvxkuaf-f1.webp)
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
皮肤病与性病 2010年6月第32卷第2期 J Dermatology and Venereology,Jun 2010,Vol.32,No.2 ㊃综述㊃肌内膜浸润CD 8+T 淋巴细胞占绝对优势,这些浸润往往在非变性的纤维周围和有时似乎也入侵纤维内㊂这表明,有一种免疫反应是针对肌纤维的㊂相比之下,血管周围浸润以CD 4+T 淋巴细胞为主和一些巨噬细胞,且有时也有B 淋巴细胞㊂这就提示了有一种免疫反应是以微血管为靶器官的㊂在PM 和DM(但不包括IBM)可发现肌炎特异及非特异性自身抗体,支持了B 淋巴细胞㊁CD 4+T 细胞在IIM 的作用[12]㊂在部分患者尤其是能检测出自身抗体的患者发现与HLA-DRB1*0301,DQA1*0501,DQB1*0201有遗传相关性,进一步支持了CD 4+
T 淋巴细胞在发病机制中的作用㊂
各学科的新的进展,可以帮助进一步了解免疫机制在
IIM 中的重要作用㊂总之,他们免疫系统在这些疾病表现了复杂性,固有和适应性免疫系统都参与了IIMS,因此有必要不断完善或修改 既往的假说”㊂近来关于最恰当和准确的诊断标准,就包括了组织病理学的重要性和免疫细胞的定位㊂其他,如自身抗体的分型可能也会成为疾病亚型分类的重要指标,这将有助于提高认识疾病的机制和从而改善治疗和预后㊂参考文献:
[1]Arahata K,Engel AG.Monoclonal antibody analysis of mononuclear cells in myopathies.I:Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers inva⁃ded by T cells[J].Ann Neurol 1984,16:193-208.
[2]Pedrol E,Grau JM,Casademont J,et al.Idiopathic inflammatory my⁃opathies.Immunohistochemical analysis of the major histocompatibility complex antigen expression,inflammatory infiltrate phenotype and activa⁃tion cell markers[J].Clin Neuropathol 1995,14:179-184.[3]Engel AG,Arahata K,Emslie-Smith A.Immune effector mechanisms in inflammatory myopathies[J].Res Publ Assoc Res Nerv Ment Dis 1990,68:141-157.
[4]Orimo S,Koga R,Goto K,et al.Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies [J].Neuromuscul Disord 1994,4:219-226.[5]Dalakas MC,Hohlfeld R.Polymyositis and dermatomyositis[J].Lan⁃cet 2003,362:971-982.
[6]Ikezoe K,Ohshima S,Osoegawa M,et al.Expression of granulysin in polymyositis and inclusion-body myositis[J].J Neurol Neurosurg Psychia⁃try 2006,77:1187-1190.
[7]Benveniste O,Cherin P,Maisonobe T,et al.Severe perturbations of
the blood T cell repertoire in polymyositis,but not dermatomyositis patients [J].J Immunol 2001,167:3521-3529.[8]Benveniste O,Herson S,Salomon B,et al.Long-term persistence of clonally expanded T cells in patients with polymyositis [J].Ann Neurol 2004,56:867-872.
[9]Fathi M,Dastmalchi M,Rasmussen E,et al.Interstitial lung disease,a common manifestation of newly diagnosed polymyositis and dermatomyosi⁃tis[J].Ann Rheum Dis 2004,63:297-301.[10]Vencovsky J,Jarosova K,Machacek S,et al.Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis [J].Scand J Rheumatol 2000,29:95-102.[11]Greenberg SA,Bradshaw EM,Pinkus JL,et al.Plasma cells in mus⁃
cle in inclusion body myositis and polymyositis[J].Neurology 2005,65:1782-1787.
[12]Brouwer R,Hengstman GJ,Vree Egberts W,et al.Autoantibody profiles in the sera of European patients with myositis[J].Ann Rheum Dis 2001,60:116-123.
[13]Page G,Sattler A,Kersten S,et al.Plasma cell-like morphology of Th1-cytokine-producing cells associated with the loss of CD3expression [J].Am J Pathol 2004,164:409-417.
[14]Levine TD.Rituximab in the treatment of dermatomyositis:an open-label pilot study[J].Arthritis Rheum 2005,52:601-607.
[15]Jego G,Palucka AK,Blanck JP,et al.Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin
6[J].Immunity 2003,19:225-234.[16]Greenberg SA,Pinkus GS,Amato AA,et al.Myeloid dendritic cells in inclusion-body myositis and polymyositis[J].Muscle Nerve 2007,35:17-23.
[17]Greenberg SA,Pinkus JL,Pinkus GS,et al.Interferon-α/β-medi⁃ated innate immune mechanisms in dermatomyositis [J ].Ann Neurol 2005,57:664-678.
[18]Oppenheim JJ,Yang D,Biragyn A,et al.Chemokine receptors on dendritic cells promote autoimmune reactions[J].Arthritis Res 2002,4(Suppl 3):183-188.
[19]Murata KY,Sugie K,Takamure M,et al.Expression of the costimu⁃latory molecule BB -1and its receptors in patients with scleroderma –polymyositis overlap syndrome[J].J Neurol Sci 2002,205:65-70.[20]Chevrel G.Page G.Miossec P;Novel aspects on the contribution of T cells and dendritic cells in the pathogenesis of myositis[J].Autoimmuni⁃
ty,2006,39(3):171-176.
【收稿日期】2009-08-12
白三烯及抗白三烯药物与皮肤病相关性的研究进展
肖 沙,陈德宇,杨西群(泸州医学院附属医院皮肤科,四川
泸州 646000)
摘要:白三烯作为一种重要的炎症介质参与了多种皮肤病的发生发展,抗白三烯药物对皮肤病的治疗也有一定的疗效㊂本文回顾了白三烯与相关皮肤病的文献,阐述了白三烯在皮肤病发展中的作用以及抗白三烯药物在皮肤病治疗中的应用㊂
关键词:白三烯;皮肤病;发病机制;治疗;综述㊂
中图分类号:Q946.48;R751 文献标识码:A doi :10.3969/j.issn.1002-1310.2010.02.011
Leukotriene ,anti -leukotriene drugs and dermatosis (Review )
XIAO Sha,CHEN De-yu,YANG Xi-qun (Department of Dermatology,the affiliated Hospital of Luzhou Medical College,Sichuan Luzhou 646000Chi⁃
na)
9
1